资讯

Targeted Oncology21 小时
Italian Study Highlights Real-World Data for Melphalan Flufenamide in Myeloma
Melphalan flufenamide (melflufen) is approved in Europe for relapsed/refractory multiple myeloma, but the FDA withdrew its ...